Physician profile
Ryan John Wise
NPI 1932542842
$2,085.64
in general payments reported to CMS, 2019-2025
23 companies · $633 in 2025
The $633 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $349 · 2020: $117 · 2021: $112 · 2022: $66.84 · 2023: $420 · 2024: $387 · 2025: $633.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,440.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,439.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $396.05 | 2019-2025 | Hydrus Microstent, Clareon, Unity |
| Sun Pharmaceutical Industries INC. | $359.14 | 2019-2025 | |
| Abbvie INC. | $235.11 | 2023-2025 | Durysta |
| Sight Sciences, INC. | $171.17 | 2022-2025 | Omni Surgical System |
| Bausch & Lomb Americas INC. | $133.27 | 2023-2025 | Vyzulta, Miebo, Xiidra |
| Thea Pharma INC. | $122.27 | 2023-2025 | Iyuzeh |
| Lensar, INC. | $112.14 | 2025 | Lensar Laser System |
| Amgen INC. | $107.93 | 2024-2025 | Tepezza |
| Kala Pharmaceuticals, INC. | $86.94 | 2019-2021 | |
| Aerie Pharmaceuticals, INC. | $44.78 | 2019-2021 | |
| Rayner Intraocular Lenses Limited | $43.68 | 2023 | Rayone Aspheric, Rayone Spheric, Rayone Emv |
| Allergan, INC. | $34.02 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $33.01 | 2025 | Xdemvy |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $29.05 | 2019 | |
| Novartis Pharmaceuticals Corporation | $27.62 | 2023 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $27.31 | 2019 | |
| Oyster Point Pharma, INC. | $24.88 | 2023 | Tyrvaya |
| Shire North American Group INC | $20.76 | 2019 | |
| Carl Zeiss Meditec USA, INC. | $18.88 | 2023 | Veracity Surgical |
| Ivantis, INC | $16.00 | 2021 | |
| Rxsight INC | $14.29 | 2025 | Rxsight Injector Cartridge, Rxsight Contact Lens, Rxsight Injector Handpiece |
| Johnson & Johnson Surgical Vision, INC. | $14.22 | 2019 | |
| Eyepoint US, INC. | $13.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Wise listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.